MEDP
Medpace Holdings, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Buy
+20/100
Last price
602.90
▼ 17.61 (2.84%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
620.51
Day high
642.65
Day low
601.36
Volume
219.13K
Market cap
$16.83B
P/E (TTM)
35.40
52W range
373.00 – 677.90
Trailing performance
Returnvs SPY
1W
-3.09%
-5.0%
1M
+1.96%
+0.8%
3M
+13.33%
+8.8%
6M
+18.56%
+0.4%
YTD
+7.34%
-6.9%
1Y
+13.22%
-3.2%
3Y
+149.00%
+66.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on MEDP open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
-260.72K
Net selling
Buy transactions
11
48.65K shares
Sell transactions
20
309.37K shares
Net transactions
+31
Buys less sells
Sell : buy shares
6.4 : 1
Heavily one-sided
Insider-held shares
5.23M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 30, 26 | TROENDLE AUGUST J Chief Executive Officer |
SELL | 48.67K | $30.32M | Direct |
| Sep 28, 26 | TROENDLE AUGUST J Chief Executive Officer |
SELL | 2.56K | $1.59M | Direct |
| Sep 22, 26 | TROENDLE AUGUST J Chief Executive Officer |
SELL | 70.90K | $44.43M | Direct |
| Sep 17, 26 | TROENDLE AUGUST J Chief Executive Officer |
SELL | 10.88K | $6.75M | Direct |
| Sep 16, 26 | TROENDLE AUGUST J Chief Executive Officer |
SELL | 24.74K | $15.36M | Direct |
| Sep 15, 26 | BURWIG SUSAN ELIZABETH Officer |
CONVERSION | 3.00K | $500.19K | Direct |
| Aug 27, 26 | TROENDLE AUGUST J Chief Executive Officer |
SELL | 650 | $403.18K | Direct |
| Aug 26, 26 | TROENDLE AUGUST J Chief Executive Officer |
SELL | 4.67K | $2.90M | Direct |
| Aug 26, 26 | KRAFT ROBERT O Director |
SELL | 3.86K | $2.38M | Direct |
| Aug 26, 26 | KRAFT ROBERT O Director |
CONVERSION | 3.86K | $325.46K | Direct |
| Aug 24, 26 | TROENDLE AUGUST J Chief Executive Officer |
SELL | 15.98K | $9.97M | Direct |
| Aug 20, 26 | BRADY KEVIN M. Chief Financial Officer |
SELL | 3.40K | $2.13M | Direct |
| Aug 20, 26 | TROENDLE AUGUST J Chief Executive Officer |
SELL | 42.78K | $26.28M | Direct |
| Aug 20, 26 | BRADY KEVIN M. Chief Financial Officer |
CONVERSION | 3.40K | $472.16K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BRADY KEVIN M. |
Chief Financial Officer | 12.83K | Sale |
BURWIG SUSAN ELIZABETH |
Officer | 65.98K | Conversion of Exercise of derivative security |
CARLEY BRIAN T |
Director | 27.82K | Sale |
DAVENPORT FRED B JR |
Director | 5.80K | Sale |
EWALD STEPHEN P |
General Counsel | 20.34K | Sale |
GEIGER JESSE J |
President | 15.00K | Sale |
KRAFT ROBERT O |
Director | 955 | Sale |
MCCARTHY CORNELIUS P. III |
Director | 12.28K | Sale |
TROENDLE AUGUST J |
Chief Executive Officer | 5.07M | Sale |
Fundamentals
Market cap$16.83B
Enterprise value$16.47B
Revenue (TTM)$2.78B
Gross profit$2.01B
EBITDA$611.20M
Net income$491.50M
EPS (TTM)$17.03
Free cash flow$510.40M
Total cash$502.69M
Total debt$144.11M
Book value / share$15.55
Shares outstanding27.91M
Float22.66M
Short % of float7.53%
Dividend yield0.00%
Beta (5Y)1.18
Valuation & profitability ratios
Trailing P/E35.40
Forward P/E31.21
PEG ratio2.87
Price / sales—
Price / book38.78
EV / revenue5.92
EV / EBITDA26.95
Gross margin72.35%
Operating margin20.76%
Profit margin17.66%
Return on equity162.15%
Return on assets20.10%
Debt / equity33.22
Current ratio0.73
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $2.53B | $2.11B | $1.89B | $1.46B | +20.0% |
| Operating revenue | $2.53B | $2.11B | $1.89B | $1.46B | +20.0% |
| Cost of revenue | $1.77B | $1.45B | $1.36B | $1.03B | +21.8% |
| Gross profit | $760.62M | $656.30M | $524.50M | $432.44M | +15.9% |
| Selling, general & admin | $197.56M | $180.18M | $161.35M | $131.40M | +9.6% |
| Total operating expense | $225.68M | $209.44M | $187.68M | $153.74M | +7.8% |
| Operating income | $534.93M | $446.87M | $336.82M | $278.70M | +19.7% |
| Net interest income | $12.78M | $25.00M | -$488.00K | -$2.90M | -48.9% |
| Pre-tax income | $542.38M | $475.92M | $335.68M | $282.86M | +14.0% |
| Tax provision | $91.25M | $71.54M | $52.87M | $37.49M | +27.6% |
| Net income | $451.12M | $404.39M | $282.81M | $245.37M | +11.6% |
| Net income to common | $451.12M | $404.34M | $282.62M | $245.21M | +11.6% |
| Basic EPS | 15.64 | 13.06 | 9.20 | 7.57 | +19.8% |
| Diluted EPS | 15.28 | 12.63 | 8.88 | 7.28 | +21.0% |
| EBIT | $534.93M | $446.87M | $336.82M | $278.70M | +19.7% |
| EBITDA | $563.06M | $476.12M | $363.15M | $301.04M | +18.3% |
| Basic shares | 28.85M | 30.96M | 30.72M | 32.39M | -6.8% |
| Diluted shares | 29.53M | 32.01M | 31.84M | 33.67M | -7.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $497.05M | $669.44M | $245.45M | $28.27M | -25.8% |
| Cash & short-term investments | $497.05M | $669.44M | $245.45M | $28.27M | -25.8% |
| Accounts receivable | $376.75M | $291.10M | $275.93M | $213.17M | +29.4% |
| Total current assets | $989.62M | $1.03B | $593.83M | $333.96M | -3.8% |
| Property, plant & equipment | $248.87M | $252.26M | $265.39M | $248.92M | -1.3% |
| Goodwill & intangibles | $695.82M | $696.76M | $698.21M | $700.40M | -0.1% |
| Total assets | $1.98B | $2.10B | $1.66B | $1.35B | -6.0% |
| Total current liabilities | $1.34B | $1.10B | $925.13M | $803.47M | +21.7% |
| Current debt | — | — | — | $50.00M | — |
| Total debt | $113.64M | $126.23M | $142.12M | $188.87M | -10.0% |
| Total liabilities | $1.52B | $1.28B | $1.10B | $966.11M | +18.9% |
| Retained earnings | -$459.98M | $8.17M | -$221.65M | -$359.83M | -5,732.2% |
| Shareholder equity | $459.07M | $825.54M | $558.95M | $386.39M | -44.4% |
| Working capital | -$354.12M | -$75.32M | -$331.30M | -$469.51M | -370.1% |
| Net tangible assets | -$236.75M | $128.78M | -$139.25M | -$314.02M | -283.8% |
| Shares issued | 28.44M | 30.70M | 30.82M | 31.16M | -7.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $451.12M | $404.39M | $282.81M | $245.37M | +11.6% |
| Depreciation & amortisation | $28.12M | $29.25M | $26.33M | $22.34M | -3.9% |
| Stock-based compensation | $34.79M | $25.51M | $20.52M | $21.41M | +36.3% |
| Change in working capital | $96.28M | $157.18M | $106.49M | $106.06M | -38.7% |
| Operating cash flow | $713.22M | $608.82M | $433.37M | $388.05M | +17.1% |
| Capital expenditure | -$31.36M | -$36.55M | -$36.65M | -$36.88M | +14.2% |
| Investing cash flow | -$31.14M | -$28.31M | -$34.63M | -$38.74M | -10.0% |
| Share buybacks | -$917.39M | -$169.87M | -$144.02M | -$847.85M | -440.1% |
| Financing cash flow | -$860.39M | -$154.01M | -$182.64M | -$775.77M | -458.7% |
| Free cash flow | $681.87M | $572.27M | $396.73M | $351.17M | +19.2% |
| End cash position | $497.05M | $669.44M | $245.45M | $28.27M | -25.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $707.33M | $706.60M | $708.45M | $659.90M | $603.31M | +0.1% |
| Operating revenue | $707.33M | $706.60M | $708.45M | $659.90M | $603.31M | +0.1% |
| Cost of revenue | $505.69M | $510.28M | $503.13M | $462.96M | $423.30M | -0.9% |
| Gross profit | $201.64M | $196.33M | $205.32M | $196.94M | $180.01M | +2.7% |
| Selling, general & admin | $48.10M | $47.92M | $44.92M | $48.08M | $46.66M | +0.4% |
| Total operating expense | $54.81M | $54.82M | $52.05M | $55.13M | $53.68M | -0.0% |
| Operating income | $146.82M | $141.50M | $153.27M | $141.81M | $126.33M | +3.8% |
| Net interest income | $4.99M | $5.12M | $3.72M | $1.52M | $1.08M | -2.6% |
| Pre-tax income | $151.66M | $147.59M | $156.83M | $142.84M | $124.54M | +2.8% |
| Tax provision | $30.30M | $23.72M | $21.70M | $31.70M | $34.28M | +27.7% |
| Net income | $121.36M | $123.87M | $135.13M | $111.14M | $90.26M | -2.0% |
| Net income to common | $121.36M | $123.87M | $135.13M | $111.14M | $90.26M | -2.0% |
| Basic EPS | 4.31 | 4.35 | 4.78 | 3.95 | 3.16 | -0.9% |
| Diluted EPS | 4.25 | 4.28 | 4.67 | 3.86 | 3.10 | -0.7% |
| EBIT | $146.82M | $141.50M | $153.27M | $141.81M | $126.33M | +3.8% |
| EBITDA | $153.53M | $148.41M | $160.40M | $148.86M | $133.35M | +3.5% |
| Basic shares | 28.17M | 28.45M | 28.29M | 28.14M | 28.60M | -1.0% |
| Diluted shares | 28.55M | 28.96M | 28.96M | 28.82M | 29.14M | -1.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $502.69M | $652.68M | $497.05M | $285.35M | $46.33M | -23.0% |
| Cash & short-term investments | $502.69M | $652.68M | $497.05M | $285.35M | $46.33M | -23.0% |
| Accounts receivable | $420.56M | $370.41M | $376.75M | $362.32M | $371.92M | +13.5% |
| Total current assets | $1.05B | $1.14B | $989.62M | $737.28M | $520.80M | -7.8% |
| Property, plant & equipment | $282.96M | $263.36M | $248.87M | $256.76M | $264.99M | +7.4% |
| Goodwill & intangibles | $695.51M | $695.66M | $695.82M | $696.05M | $696.29M | -0.0% |
| Total assets | $2.06B | $2.13B | $1.98B | $1.75B | $1.57B | -3.4% |
| Total current liabilities | $1.44B | $1.35B | $1.34B | $1.28B | $1.22B | +6.7% |
| Total debt | $120.10M | $122.26M | $113.64M | $119.07M | $124.95M | -1.8% |
| Total liabilities | $1.62B | $1.53B | $1.52B | $1.46B | $1.40B | +6.0% |
| Retained earnings | -$511.37M | -$336.11M | -$459.98M | -$596.24M | -$703.22M | -52.1% |
| Shareholder equity | $433.86M | $598.31M | $459.07M | $293.64M | $172.35M | -27.5% |
| Working capital | -$385.14M | -$205.96M | -$354.12M | -$546.63M | -$699.64M | -87.0% |
| Net tangible assets | -$261.64M | -$97.35M | -$236.75M | -$402.41M | -$523.94M | -168.8% |
| Shares issued | 27.91M | 28.63M | 28.44M | 28.24M | 28.16M | -2.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $121.36M | $123.87M | $135.13M | $111.14M | $90.26M | -2.0% |
| Depreciation & amortisation | $6.71M | $6.91M | $7.13M | $7.05M | $7.01M | -2.8% |
| Stock-based compensation | $4.35M | $4.92M | $5.62M | $6.32M | $5.95M | -11.6% |
| Change in working capital | $19.40M | -$8.70M | $22.12M | $87.46M | $5.59M | +323.1% |
| Operating cash flow | $162.01M | $151.79M | $192.65M | $246.21M | $148.53M | +6.7% |
| Capital expenditure | -$23.91M | -$6.81M | -$4.54M | -$10.71M | -$6.11M | -250.9% |
| Investing cash flow | -$23.89M | -$6.75M | -$4.47M | -$10.66M | -$6.02M | -254.0% |
| Share buybacks | -$294.76M | $0 | $0 | -$4.57M | -$540.91M | — |
| Financing cash flow | -$288.34M | $12.67M | $22.73M | $3.41M | -$540.56M | -2,375.8% |
| Free cash flow | $138.10M | $144.97M | $188.12M | $235.50M | $142.41M | -4.7% |
| End cash position | $502.69M | $652.68M | $497.05M | $285.35M | $46.33M | -23.0% |
Options analytics
Put / call volume
4.64
Put-heavy session
Put / call open interest
4.19
Positioning, not flow
Max pain
620.00
+2.8% from spot
ATM implied vol
0.0%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
56
Contracts, this expiry
Put volume
260
Contracts, this expiry
Heaviest call OI
650.00
47 contracts
Heaviest put OI
590.00
346 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 4.00 | 4.25 | +6.2% |
| Mar 2026 | 3.96 | 4.28 | +8.2% |
| Dec 2025 | 4.23 | 4.67 | +10.5% |
| Sep 2025 | 3.57 | 3.86 | +8.1% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 4.46 | 8 | $714.47M | +8.3% |
| Next quarter | 4.68 | 8 | $720.85M | +1.8% |
| Current year | 17.71 | 10 | $2.85B | +12.7% |
| Next year | 19.32 | 10 | $3.03B | +6.3% |
Analyst targets & ownership
Mean target$591.85
High target$692.00
Low target$370.00
Implied upside-1.83%
Analyst count13
ConsensusHOLD
Strong buy / Buy1 / 1
Hold11
Sell / Strong sell1 / 0
Held by insiders18.74%
Held by institutions91.16%
Institutions holding921
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
613.98
-1.80% from price
SMA 20
610.55
-1.25% from price
SMA 50
600.79
+0.35% from price
SMA 100
546.19
+10.38% from price
SMA 200
524.35
+14.98% from price
EMA 12
611.47
-1.40% from price
EMA 26
607.57
-0.77% from price
EMA 50
593.12
+1.65% from price
RSI (14)
48.2
Neutral
MACD (12,26,9)
3.90
Hist -2.29
ATR (14)
18.88
3.13% of price
Realised vol 30D
26.5%
Annualised
Bollinger upper
638.21
20, 2σ
Bollinger lower
582.89
20, 2σ
50 / 200 cross
Golden
600.79 vs 524.35
Trend bias
Above 200
+14.98%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.71
Less volatile than market
Correlation to SPY
0.21
Largely independent
Realised vol 30D
26.5%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-36.6%
Peak to trough
Max drawdown 5Y
-42.9%
Peak to trough
ATR 14
18.88
3.13% of price
Beta (reported)
1.18
5Y monthly, from filing
Short interest
Shares short
1.69M
Prior 1.58M
Change vs prior
+6.8%
Shorts adding
% of float
7.53%
Normal
% of shares out
6.04%
Against total outstanding
Days to cover
8.5
Crowded exit
Float
22.66M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 30, 26 | UBS | UPGRADE | Sell | Neutral |
| Jul 24, 26 | Mizuho | MAINTAINED | Outperform | Outperform |
| Jul 24, 26 | BMO Capital | MAINTAINED | Market Perform | Market Perform |
| Jul 24, 26 | Truist Securities | MAINTAINED | Hold | Hold |
| Jul 24, 26 | TD Cowen | MAINTAINED | Hold | Hold |
| Jul 24, 26 | RBC Capital | MAINTAINED | Outperform | Outperform |
| Jul 24, 26 | Baird | MAINTAINED | Neutral | Neutral |
| Jul 13, 26 | Mizuho | MAINTAINED | Outperform | Outperform |
| Jul 8, 26 | Baird | DOWNGRADE | Outperform | Neutral |
| Jul 7, 26 | Jefferies | DOWNGRADE | Buy | Hold |
| Apr 24, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
| Apr 24, 26 | BMO Capital | MAINTAINED | Market Perform | Market Perform |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Periodic Financial Reports
10-Q · 2026-07-23
Corporate Changes & Voting Matters
8-K · 2026-07-22
Corporate Changes & Voting Matters
8-K · 2026-06-04
Corporate Changes & Voting Matters
8-K · 2026-05-19
Periodic Financial Reports
10-Q · 2026-04-23
Corporate Changes & Voting Matters
8-K · 2026-04-22
Proxy Statements
DEFA14A · 2026-04-01
Proxy Statements
PRE 14A · 2026-03-16
Headlines
Medpace (MEDP) Stock Declines While Market Improves: Some Information for Investors
Zacks · 14h ago
1 Momentum Stock Worth Investigating and 2 Facing Headwinds
StockStory · 2d ago
Medpace Holdings Insider Sold Shares Worth $30,320,929, According to a Recent SEC Filing
MT Newswires · 6d ago
UBS Upgrades Medpace Holdings to Neutral From Sell, Adjusts Price Target to $673 From $405
MT Newswires · 7d ago
Medpace (MEDP) Rises As Market Takes a Dip: Key Facts
Zacks · 8d ago
Medpace Holdings Insider Sold Shares Worth $1,589,941, According to a Recent SEC Filing
MT Newswires · 8d ago
CON or MEDP: Which Is the Better Value Stock Right Now?
Zacks · 9d ago
3 Market-Beating Stocks with Promising Prospects
StockStory · 14d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.